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The influence of antibody immune selective pressure on Newcastle disease virus (NDV) HN and F gene mutations was studied 
in cell cultures. NDV field strain TZ060107 was inoculated into chicken embryo fibroblast cells and continuously passaged 
with (group A) or without (group B) anti-NDV monospecific serum. Each group contained three independent passage series. 
HN and F genes were amplified and sequenced for the 10th, 20th, 30th, 40th and 50th generations of each serial passage, and 
compared with the original strain. The results demonstrated that increased HN gene mutations were observed in group A with 
the antibody than in group B without the antibody. The nonsynonymous (NS) to synonymous (S) mutations ratio was 6 for 
group A, significantly higher than 3.4 in group B. In group A with the antibody, there were five stable NS mutations in HN 
gene, three of which (related to aa#353, 521 and 568) were related to known epitopes. There were two stable NS mutations in 
F gene in group A, but no stable NS mutations in group B. The NS/S ratios of F gene were less than 2.5 for both groups A and 
B. Our results suggested that the antibody strongly influenced HN gene mutations, while the F gene was less influenced by the 
same antibody.  
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Newcastle disease (ND) is an acute infectious disease in 
chickens caused by the avian paramyxovirus type 1 virus, 
Newcastle disease virus (NDV). It is one of the most serious 
diseases for economic losses in the poultry industry in 
China. NDV is an enveloped RNA virus with a single 
non-segmented negative strand. Its genome contains six 
genes encoding the nucleoprotein, phosphoprotein, matrix 
protein, fusion protein (F), hemagglutinin-neuraminidase 
(HN), and polymerase [1]. The capsule of NDV is com-
posed of F and HN glycoproteins. F glycoprotein can fuse to 
host cell membrane and HN glycoprotein has hemagglutina-
tion and neuraminidase activities. Both F and HN are in-
volved in cell recognition and attachment during infection, 
and are the main genes associated with NDV virulence [2–5]. 
NDV has only one serotype, but it is divided into nine 
genotypes based on F gene sequences. Each NDV genotype 
may exhibit differences in virulence and origin [6]. At pre-
sent, genotype VII is the most prevalent NDV in China. 
Although most chicken farms have continuously conducted 
comprehensive vaccination programs against ND for many 
years in China, NDV infection is still common nationwide. 
Besides fatal acute or subacute cases, most NDV infections 
cause serious reductions in egg production and subsequent 
economic losses. It has been speculated that antigenic varia-
tion occurs within NDV field strains and was responsible 
for vaccination failures, although evidence of this remains 
inconclusive.  
In recent years, our laboratory has studied the evolution 
of the gp85 gene in the subgroup J avian leukosis virus and 
the hemagglutinin gene in the H9N2 subtype avian influ-
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enza virus under antibody selective pressure [7,8]. This 
study attempts to use similar experimental methodology to 
understand if mutations in NDV HN and F genes could be 
increased under the selective pressure of anti-NDV anti-
bodies. 
1  Materials and methods 
1.1  Virus  
NDV field strain TZ060107 (genotype VII) was used in this 
study. The virus was isolated from chicken embryos from a 
breeding farm, with reduced egg production, in 2006 [9]. 
1.2  Preparation of cell cultures 
Chicken embryo fibroblast cells (CEF) were prepared from 
10-day-old specific pathogen free (SPF) chicken embryos 
and used for NDV passage. 
1.3  Preparation of anti-NDV chicken serum and de-
termination of its optimal dilutions for cell cultures 
Eight 21-day-old SPF chickens were intramuscularly in-
oculated with 0.5 mL of inactivated NDV strain TZ060107 
vaccine in an oil emulsion. SPF chickens were raised in an 
isolator with positively pressured filtered-air. Chickens 
were vaccinated again two weeks later. Ten days after the 
second vaccination, chickens were bled and serum samples 
were collected as antiserum against NDV strain TZ060107. 
The hemagglutination inhibition titers (HI) ranged from 28 
to 210. All serum samples were combined in a centrifuge 
tube and spun at 10000 r min−1. Serum was then filtered 
through a 0.22 μm filter and inactivated at 56°C for 30 min 
and stored at −20°C before use. 
The original NDV strain TZ060107 was titrated in 
96-well plates with CEF and the virus stock TCID50 was 
calculated according to the Reed-Muench method. The pri-
mary virus neutralization test was conducted to determine 
the optimal dilution of the antiserum for the subsequent 
serial passages. It was carried out using virus of a fixed di-
lution and serum of different dilutions in a six-well plate 
containing CEF monolayers. Two control wells were used. 
One well contained the virus only and the other contained 
the antiserum only. The other four wells contained mixtures 
of the virus and antiserum at 1:10, 1:20, 1:50 and 1:100 
dilutions. Plates were incubated for 72 h at 37°C with 5% 
CO2. CEF monolayers were predicted to be normal in the 
serum only control well and reduced, with rounded cells, in 
the virus only control well. The virus cytopathic effect (CPE) 
was observed and compared in the four left wells. The low-
est serum dilution used in wells that demonstrated CPE was 
chosen for the following passages. 
1.4  Serial passages of NDV strain TZ060107 in CEF  
CEF monolayers for NDV strain TZ060107 inoculation 
were prepared and maintained in culture medium with 1% 
fetal bovine serum in six-well plates. Wells for each passage 
were divided into groups A and B. Wells for group A were 
supplemented with anti-TZ060107 chicken serum at the 
specific dilution determined in 1.3. Wells for group B 
without anti-TZ060107 serum were used as controls. An 
identical amount of NDV from the same stock of strain 
TZ060107 was inoculated into each well. In the first pas-
sage, three wells were designated as lineages A1-1, A2-1 and 
A3-1 for group A and B1-1, B2-1 and B3-1 for group B. 
When 50% of the monolayer cells demonstrated CPE, 100 µL 
of supernatant from each well was collected and inoculated 
separately into another six-well plate with fresh CEF 
monolayers. The six wells in the second plate were also 
divided as described above; however, wells were designated 
as lineages A1-2, A2-2 and A3-2 for group A and B1-2, 
B2-2, and B3-2 for group B for the second passages. These 
steps were repeated for 50 passages. Every 10 passages, the 
supernatants in each well of the six lineages were harvested 
for the viruses and stored at −70°C. 
1.5  Amplification, cloning and sequencing of HN and F 
genes 
Whole genomic RNA in the supernatants from each well of 
the A1–A3 and B1–B3 lineages at the 10th, 20th, 30th, 40th 
and 50th passages was extracted using TRizol reagent (In-
vitrogen, Cat No. 15596-026) according to the manufac-
turer’s instructions. Primers for F gene amplification (1725 
bp) were F1: 5′-GGCAAATTAGAAAAAACACGGG-3′ and 
F2: 5′-CTCTTGTAGTGGCTCTCATCT-3′; primers for HN 
gene amplification (1801 bp) were HN1: 5′-TCCGTTCTA- 
CCAATCACCA-3′ and HN2: 5′-CGTCTTCCCAACCAT- 
CCTAT-3′. Primers were synthesized by Shanghai Sangon 
Co., Ltd., China. 
Reverse transcription-polymerase chain reaction (RT-     
PCR) amplification was conducted using a TaKaRa RNA 
PCR Kit (AMV) Ver.3.0 (TaKaRa Biotechnology Co., Ltd.) 
according to the manufacturer’s instructions. RT-PCR reac-
tion conditions for the HN gene were 95°C denaturation for 
6 min, 95°C for 1 min, 54°C for 1 min and 72°C for 2 min 
for a total of 32 cycles, 72°C extension for 10 min and 4°C 
to terminate the reaction. RT-PCR reaction conditions for 
the F gene were 95°C denaturation for 6 min, 95°C for 1 
min, 54°C for 1 min and 72°C for 1 min 45 s for a total of 
32 cycles, 72°C extension for 10 min and 4°C to terminate 
the reaction. 
Cloning, identification and sequencing of the HN and F 
genes were conducted by cloning PCR products into 
pMD18-T and sequencing using commercial services. 
476 Gong Y Y, et al.   Sci China Life Sci   May (2011) Vol.54 No.5 
 
1.6  Analysis of ratios of non-synonymous and syn-
onymous mutations in HN and F gene sequences  
DNA Star software was used for analysis and comparison. 
Non-synonymous (NS) and synonymous (S) mutation ratios 
(NS/S value) were analyzed and compared according to 
published methods [10]. 
2  Results  
2.1  Determination of the highest anti-NDV serum con-
centration required for partial virus replication inhibi-
tion  
Virus neutralization indicated that virus replication was 
completely inhibited in media with anti-NDV chicken se-
rum at a 1:20 dilution. However, viruses could still repli-
cate at different levels in media with identical serum at 1:50 
and 1:100 dilutions. Therefore, anti-NDV chicken serum at 
a 1:50 dilution was used for the subsequent 50 serial pas-
sages of the A1, A2 and A3 lineages. 
2.2  Stability of HN and F gene sequences in different 
passages  
Sequence comparisons showed that the amplified HN gene 
fragments were composed of 1801 bp and contained a com-
plete open reading frame (1716 bp) in all passages. The F 
gene fragments were composed of 1725 bp and contained a 
complete open reading frame (1662 bp). After 50 passages, 
different levels of variation were detected in different pas-
sage serials, although all viruses maintained a 99% homol-
ogy to the original virus (GenBank accession No. 
FJ011444.1 and FJ011448.1). 
2.3  Variations during the serial passages with anti- 
NDV serum 
In group A, 67 different base mutations were observed in 
the HN gene. Among them, 61 were non-synonymous mu-
tations located at 30 different sites and six were synony-
mous in six different sites. A total of 38 mutations were 
observed in the F gene, 24 of them were non-synonymous 
mutations located at 15 different sites and 14 were synony-
mous mutations at 11 different sites. These results revealed 
that the NS/S ratio for the HN gene in group A was 30/6 (5), 
while the NS/S ratio for the F gene in group A was only 
15/11 (1.36).  
Stable mutations mainly occurred during the 20th–50th 
passages and the mutated sites usually became stable after 
30 passages (Table 1). Five mutation sites in the HN gene 
were stable in more than two consecutive passages. The 
NS/S ratio in these five sites was 5/0, demonstrating the 
immune selective pressure effect of the anti-NDV antibody. 
Among these five sites, two had the same mutation in two 
separate lineages. Another two mutations at base #1439 and 
#1703 were identical in the three independent lineages A1, 
A2 and A3 (Table 1). Stable mutations in at least two con-
secutive passages were found at three sites in the F gene, 
with a NS/S ratio of 2/1 (2).  
2.4  Variations during the serial passages without 
anti-NDV serum 
NDV TZ060107 strain was also continuously passaged in 
CEF without antibodies, and a total 24 mutations occurred 
in the HN gene at 19 different sites. Among them, 20 were 
NS mutations found at 15 sites. Only one stable NS muta-
tion occurred in more than two consecutive passages in one 
serial passage (Table 1). A further four S mutations were 
located at four sites, with a NS/S ratio of 15/4 (3.75). A 
total of 17 mutations occurred in the F gene at 15 sites, of 
which, nine were NS mutations located in eight sites and 
eight were S mutations located at seven sites, with a NS/S 
ratio of 8/7 (1.14). Overall, the F gene nucleotide variation 
was a result of random mutation and no stable mutations 
occurred in two consecutive passages. 
2.5  Influence of the antibody on the ratios of NS/S 
mutations of F and HN genes during passages 
The NS/S ratios for the HN and F genes in both groups A 
and B are listed in Table 2. There were more NS mutations 
and higher NS/S ratios for the group A HN gene than group 
B. However, such differences between groups were not as 
large for the F gene when compared to the HN gene, indi-
cating that antibody-mediated immune selective pressure 
was higher for the HN gene than for the F gene.  
3  Discussion  
During interaction with the host, viruses continue to pro-
duce genetic mutations via various evolutionary processes. 
Recently, much attention has been focused on the influence 
of immune selective pressures in virus evolution. For exam-
ple, human immunodeficiency virus (HIV) envelope glyco-
protein genes were reported to have a high mutation fre-
quency, and their 3rd hr-region (V3 loop) can have mutation 
rates as high as 50% [11]. The V3 loop of HIV1 was closely 
related to its cell tropism, replication kinetics and cellular 
pathogenicity, and the mutations in the V3 loop could po-
tentially help viruses escape attacks by cytotoxic T cells or 
neutralizing antibodies [12,13]. Hemagglutinin glycoprotein 
of human respiratory measles virus may also develop 
changes in its antigenicity, which helps the virus escape from 
host immune reaction, because of the influence of immune 
selective pressures [14]. These studies were based on the 
analysis of a large number of nucleotide sequences for  
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Table 1  Stable mutation sites in the HN and F genes ORF during continued passages in CEFa) 


















NS serial passages 
G(S) A(E) G(R) G(R) C(S) A(D)  A(T) A(I) 
A1-10 – – – – – –  – – 
A1-20 – – – – – –  – – 
A1-30 – G(G) – A(K) – G(G)  G(A) – 
A1-40 – G(G) A(Q) A(K) – G(G)  G(A) – 
A1 
A1-50 – G(G) A(Q) A(K) – G(G)  G(A) – 
A2-10 – – – – – –  – – 
A2-20 – – – – – G(G)  G(A) – 
A2-30 – G(G) – A(K) – G(G)  G(A) – 
A2-40 – G(G) A(Q) A(K) – G(G)  G(A) – 
A2 
A2-50 – G(G) A(Q) A(K) – G(G)  G(A) – 
A3-10 – – – – – G(G)  – – 
A3-20 – – – – A(R) G(G)  – – 
A3-30 – – – A(K) A(R) G(G)  – G(V) 
A3-40 – – – A(K) A(R) G(G)  – G(V) 
 
A3 
A3-50 – – – A(K) A(R) G(G)  – G(V) 
B1-10 – – – – – –  – – 
B1-20 – – – – – –  – – 
B1-30 A(N) – – – – –  – – 
B1-40 A(N) – – – – –  – – 
B1 
B1-50 A(N) – – – – –  – – 
B2-10 – – – – – –  – – 
B2-20 – – – – – –  – – 
B2-30 – – – – – –  – – 
B2-40 A(N) – – – – –  – – 
B2 
B2-50 A(N) – – – – –  – – 
B3-10 – – – – – –  – – 
B3-20 – – – – – –  – – 
B3-30 A(N) – – – – –  – – 
B3-40 – – – – – –  – – 
 
B3 
B3-50 – – – – – –  – – 
a) Numbers with “*” indicate non-synonymous mutation sites and “−” indicates identical bases and amino acids as the original strain. One stable syn-
onymous mutation in F gene was not included. Lineages A1–A3 were passaged in CEF with antibodies and B1–B3 were passaged in CEF without antibod-
ies. 
Table 2  Comparisons for the NS/S ratios for HN and F gene mutations between passages in CEF with or without anti-NDV seruma) 
HN gene F gene Genes 
Serial passages  A1 A2 A3 Total B1 B2 B3 Total A1 A2 A3 Total B1 B2 B3 Total 
NS sites 11 12 13 36 
 
6 4 7 17 
 
6 3 8 17 
 
2 4 3 9 
S sites  2 3 1 6  1 3 1 5  4 2 5 11  1 5 2 8 
NS/S  5.5 4 13 6  6 1.33 7 3.4  1.5 1.5 1.6 1.55  2 0.8 1.5 1.125 
a) NS, non-synonymous; S, synonymous. Numbers indicate mutation sites detected during all passages, including both stable and instable mutations. 
 
 
different strains, and were assessed on the basis of NS/S 
ratios for the associated genes. In general, when the NS/S 
ratio is higher than 2.5, a selective pressure is present, such 
as the immune selective pressure. When a sufficient number 
of strains are compared, the higher the NS/S ratio is, the 
greater the role of a selective pressure [10]. In recent years, 
our laboratory, along with other research groups, have stud-
ied the influence of the immune selective pressure on the 
evolution of chicken leukemia virus [7], NDV attenuated 
vaccine [15], and H9N2 subtype avian influenza virus [8] in 
cell culture or embryonated eggs. As a continuation of the 
above work, this paper focused on the evolution of the NDV 
TZ060107 field strain during passages in CEF with 
NDV-specific antibodies. 
In group A, the majority of NS mutations appeared in the 
10th–30th passages and continued to be maintained in fur-
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ther passages. Some sites of NS mutations also occurred 
simultaneously in two or even three different passage line-
ages (Table 1). This indicates that such variation is not ran-
dom but is instead strongly influenced by antibody immune 
selective pressure, or that these mutated viruses were origi-
nally a minority quasispecies that became dominant popula-
tions during passage. By contrast, most mutations in group 
B were located randomly at various sites for different pas-
sage generations in different passage lineages. These 
changes were less stable and were likely to be random mu-
tations. HN gene mutations in group A with antibody were 
apparently more common than in group B without antibody 
(Table 2). The NS/S mutation ratio for group A was 6, in-
dicating a strong specific antibody selective pressure. For 
group B without antibody, there was only one stable NS 
mutation in the HN gene and the average NS/S ratio was 3.4, 
which was significantly smaller than group A. The stable 
mutations observed in group B may relate to its adaptation 
in chicken embryo fibroblast, another kind of selective 
pressure.  
Double selective pressures potentially existed in group A. 
There were five NS mutations in three passage lineages, 
which first occurred in the 10th–40th generations and re-
mained stable up to the 50th generation (Table 1). However, 
mutations at the same nucleotide positions were not ob-
served in any of the group B lineages, suggesting that muta-
tions of these sites were associated with the presence of 
antibodies. There were also two stable NS mutations in the 
F gene of group A. Stable NS mutations of F gene were 
absent in group B. NS/S ratios of base mutations in the F 
gene were less than 2.5 for both groups, suggesting that the 
effects of the two pressures on the F gene were not as strong 
as on HN (Table 2). This indicates that the process of NDV 
genetic evolution in the HN and F genes is relatively inde-
pendent of each other [16]. Studies on the molecular epide-
miology of the HN and F genes of NDV strains showed that 
over the last decade these genes in NDV field strains have 
deviated from those of the widely used vaccine virus LaSota 
strain, and that the HN gene variation was greater than that 
of the F gene [16]. This also suggests that antibodies 
strongly influence mutations in HN gene rather than in F 
gene. 
Because of the lack of corrective function for RNA po-
lymerase, RNA is prone to errors during replication. When 
amino acid mutations accumulate or cause epitopic varia-
tion, changes in antigenicity can occur. In cell cultures and 
particularly in vivo, virus populations can consist of quasis-
pecies that exhibit specific genomic variations in each virus 
particle. If a virus with a particular mutation has a selective 
advantage in replication compared to the original genetic 
majority, it will grow faster and become increasingly domi-
nant in the virus population. Otherwise, it will remain a ge-
netic minority or even gradually disappear from the popula-
tion if this mutation is disadvantageous. NDV mutations can 
produce epitopic changes that are no longer recognized by 
the original virus-specific antibodies. Such mutated viruses 
may subsequently become prevalent during passage with 
specific antibodies.  
In our study, genetic mutations predominantly occurred 
in the 20th–30th generations. Viruses became stable in the 
40th generation in group A, indicating that the specific im-
mune pressure to the mutated virus was no longer effective. 
Our previous study on avian leukosis virus (subgroup J) 
found that amino acid mutations were mainly in the gp85 
hypervariable region under antibody selective pressure [7], 
and that relevant mutations can occur simultaneously in 2–3 
linked amino acids. However, mutations of H9N2-AIV he-
magglutinin gene, under antibody selective pressure, were 
randomly distributed, which was consistent with the ab-
sence of a hypervariable region in this gene [8]. In our cur-
rent study, amino acid mutations of the HN and F genes 
under antibody selective pressures were distributed across 
different regions, which is also consistent with no high 
variable regions having been found in the HN and F genes 
of NDV. However, three of five NS mutations in the HN 
gene that were related to immune selective pressures 
(aa#353, 521 and 568; Table 1) were located exactly within 
three known antigenic epitopes: aa#345–353, 513–521, and 
569 [17,18]. This also verifies that the three reported epi-
topes relate to virus neutralization, and provides direct evi-
dence that these mutations are indeed associated with the 
antibody selective pressures. 
Antigenicity of the HN protein is not only determined by 
the epitope regions, but also by the protein maturity and 
molecule conformation [19]. The non-continuous region of 
the molecule may form such HN antigenic sites in the natu-
ral protein structure. In addition, there are 12 conserved 
cysteine residues in HN peptide, located at aa#172, 186, 196, 
238, 247, 251, 344, 455, 461, 465, 531 and 542, which play 
an important role in the HN maturation and the maintenance 
of its three-dimensional structure. Specific residue muta-
tions could potentially block the formation of the corre-
sponding antigenic site [20]. Such cysteine residues did not 
mutate in both groups A and B in our study, indicating that 
mutations under immune selective pressure only occur in 
given epitopes, rather than the entire three-dimensional 
structure of the molecule. 
This work was supported by the Shandong Province Application Technol-
ogy Innovation Project on Agriculture during 2007 and 2008. 
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